|
CHUK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.94333438230387E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28572716309827E-12 |
| Normal-vs-Stage2 |
9.74660000485628E-08 |
| Normal-vs-Stage3 |
4.66589999970068E-07 |
| Normal-vs-Stage4 |
2.044200E-03 |
| Stage1-vs-Stage2 |
9.941200E-01 |
| Stage1-vs-Stage3 |
7.502200E-01 |
| Stage1-vs-Stage4 |
6.925400E-01 |
| Stage2-vs-Stage3 |
7.798600E-01 |
| Stage2-vs-Stage4 |
6.690600E-01 |
| Stage3-vs-Stage4 |
8.511800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24344978758018E-13 |
| Normal-vs-AfricanAmerican |
3.10679999504515E-08 |
| Normal-vs-Asian |
1.204410E-01 |
| Caucasian-vs-AfricanAmerican |
5.329600E-01 |
| Caucasian-vs-Asian |
6.804600E-01 |
| AfricanAmerican-vs-Asian |
8.585400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63669078290241E-12 |
| Normal-vs-Female |
2.24239999999654E-05 |
| Male-vs-Female |
1.426220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.71199999732252E-08 |
| Normal-vs-Extreme_Weight |
5.99520433297585E-15 |
| Normal-vs-Obese |
2.1777002423562E-10 |
| Normal-vs-Extreme_Obese |
3.026200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.726600E-01 |
| Normal_Weight-vs-Obese |
3.511400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.380600E-01 |
| Extreme_Weight-vs-Obese |
7.772000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.089400E-01 |
| Obese-vs-Extreme_Obese |
8.594000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.64399999999354E-05 |
| Normal-vs-Age(41-60Yrs) |
2.572499990805E-10 |
| Normal-vs-Age(61-80Yrs) |
1.22124532708767E-13 |
| Normal-vs-Age(81-100Yrs) |
1.99000005363104E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.541200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.294200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.503920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.002800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.485900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.876150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.38953301590072E-12 |
| Normal-VS-Type2 PRCC |
6.89019952204717E-10 |
| Normal-VS-KIRP CIMP |
2.237500E-04 |
| Normal-VS-Unclassified PRCC |
6.753100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.976800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.885000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.046000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.121000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.784600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.566200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.57061039121709E-12 |
| Normal-vs-N1 |
2.38119999999009E-05 |
| Normal-vs-N2 |
7.636300E-02 |
| N0-vs-N1 |
2.210400E-01 |
| N0-vs-N2 |
5.973000E-01 |
| N1-vs-N2 |
3.265200E-01 |
|
|
